Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents - sprookjes - yvandenbroek - TriplyDB

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

http://www.wikidata.org/entity/Q28538891

about

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes Collective Infectious Units in Viruses Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Regulated Entry of Hepatitis C Virus into Hepatocytes.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host New perspectives for preventing hepatitis C virus liver graft infection.Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.Viral effects on the content and function of extracellular vesicles.Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.Significance of HCV RNA monitoring in the era of new potent therapies.RACK1 controls IRES-mediated translation of viruses.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin.Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014 Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.HCV Receptors and Virus Entry

P2860

Q26779128-1FF139F8-7BA1-4AA6-BEF7-D88EABF6C242 Q26801759-51031E7E-6C28-4478-8E9D-41F736F57B2A Q27928046-F1837F54-E5DB-4BFA-9809-4A97F1736F67 Q29464175-B7046A34-8058-4097-BE6B-1C7093FED8A3 Q30386551-88718A47-3324-48C9-B97A-583DF8236D44 Q33753913-60C2E486-8414-45F9-9F51-63EDB0175C9D Q34481429-314DAD65-ACF2-454D-9A2A-5EC879AA8AEF Q35598686-C429C7F8-7F38-4E3A-B6D6-CE1AEE4033ED Q35602911-5E0D2D2E-B2BA-4E52-BD7C-9CFE34D9B400 Q35745457-5D90DC3B-C2A1-4DFB-950D-3B479EB6D8AA Q35890093-7E010E24-0934-4377-B009-2673BB9228FF Q36113029-EBE6EDFA-4313-41A8-A4D9-6C2A891330D1 Q36262482-8952BF2A-18DA-4B53-96CC-1B1D9FE12058 Q36682313-B60F196C-9065-4903-984C-0DC85847BBAB Q36765305-BC915BD0-935B-4C6F-B48E-D7B15189D639 Q37015805-AECF0CBB-9A81-4586-9803-6DEB8B253256 Q37560723-A1391958-E1DF-4646-A0D9-E43730FEF5B1 Q38666881-AFDC1B63-9A5F-408A-A904-967C090BA7F0 Q38856649-9E5EEE98-DF2B-477D-9D57-BE416AA8A47C Q38899447-25AFE585-5386-4884-8B0F-EFE29B808772 Q38938490-46288D94-99AE-46D6-BE4E-792994A405B0 Q38945754-7782BF36-4613-47C3-8080-B17C48A75B44 Q39026171-4A607177-C97B-46F0-8902-702FF42ADDC6 Q39483891-4EA77060-7121-4BA6-930F-0518DD8CF4EB Q40271516-6141FFF9-C5F7-420B-806A-52D0FF0FBAB9 Q40278524-8669FAC3-8297-4DE7-B6E1-46BB6F54124A Q40334457-E946BF2A-2EAE-4B90-AA27-6BD4B232A368 Q40858663-9A5FDC29-5E8B-496D-91CE-723B67B5447C Q41033867-19BF208E-22CB-4B39-9102-09FE6230E78D Q41295530-746FE45D-ECFF-4FC7-B9BC-03C0A5D90E81 Q41488466-EA294C90-3941-4116-8A1C-B47A5A863985 Q52657367-4B9796E2-FB41-459F-B74E-8E2AD6342A4D Q57564402-76BD1AD2-A409-43B3-9E2E-332132E1ADDF

P2860

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

http://www.wikidata.org/entity/Q28538891

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@ast

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@en

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@nl

type

label

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@ast

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@en

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@nl

prefLabel

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@ast

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@en

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@nl

P1433

Q28538891-D54B6678-1864-4A17-BEB9-F4A0176B991A

P1476

Q28538891-1862FF44-9100-43A7-95C5-34C38478B6AE

P2093

Q28538891-0C13D65C-6AB2-46E5-A81E-7EA8B5080E41

Q28538891-0EA7CBD2-80CA-4A81-9868-E4A88D3ECE60

Q28538891-18CC3CF6-345E-47FB-AE7E-2664D0CBC581

Q28538891-25BEF572-B5E3-43DF-A11C-8A7AF3E58ADA

Q28538891-352A850D-709C-4801-858F-7FA3F53E0862

Q28538891-89725D58-BAAA-454C-BB8F-C09FCAE3A5FD

Q28538891-AEB10736-52AF-410D-BF50-44C6EECFAE0B

Q28538891-FC1AD7A2-2EF9-4786-A65F-3BE271C60EB3

P2860

Q28538891-02DBA99A-9DBF-48DC-9CAB-A7CA6776C394

Q28538891-04497B2C-3BC8-4DBC-B024-A8D8D108F56D

Q28538891-044AB617-016A-4260-BC13-7064814D79DE

Q28538891-0BC933DA-35EA-4345-B397-F18C03FA0C70

Q28538891-1493127D-D37B-4640-85CF-E00475FC39ED

Q28538891-19A4672D-5996-48F4-89D8-4D95EEB0C49A

Q28538891-218BCF2A-1F88-422B-A754-DE94CE90908B

Q28538891-42180209-3EEE-4D1F-A8DD-6D3E922434CE

Q28538891-442C0D87-AF1C-436B-8920-62870E9445A9

Q28538891-4ABA213A-E7E2-4EFD-BCC8-EF1F780829E7

P304

Q28538891-C24276C1-F880-4928-983B-FBF8C39AB421

P31

Q28538891-0CE72D8E-3527-43D3-873F-DABA4E887D24

P3181

Q28538891-109BA890-245A-4538-A43F-5325347EB5AD

P356

Q28538891-40B889F3-FD03-4A49-A701-3BC464564C5B

P407

Q28538891-A0B8873B-F3BC-421D-8190-45821F8713DB

P433

Q28538891-70D5DCEE-CE61-4A15-8C3D-21B7AFD7700A

P478

Q28538891-AFD607E6-15CA-4AA3-B5DC-2539DBD98AAD

P50

Q28538891-0016D43B-C7B5-4967-96D1-E2990DCB9C8D

Q28538891-81A69DBD-4AB6-4F7B-B598-CC0D17F62E47

Q28538891-F8C00A2C-2CFF-425C-8B2A-8689F32968F4

P577

Q28538891-275F17AD-1529-459D-BFB7-5AD02D89F6E5

P5875

Q28538891-D39014E9-17A0-4FD0-8ED1-1378F9904CBF

P698

Q28538891-3728CC21-693C-49F9-A498-1D2BAD6CC2E8

P921

Q28538891-07868A5D-A39D-4CBC-AD03-3C5105CF845F

P932

Q28538891-8CA05F4D-506E-468C-ACA8-271D2CA36EE7

P3181

P356

JOURNAL.PPAT.1004128

P1433

P1476

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

@en

P2093

Arvind H Patel

http://www.w3.org/2001/XMLSchema#string

Eric Soulier

http://www.w3.org/2001/XMLSchema#string

François Habersetzer

http://www.w3.org/2001/XMLSchema#string

Heidi Barth

http://www.w3.org/2001/XMLSchema#string

Isabel Fofana

http://www.w3.org/2001/XMLSchema#string

Laura Heydmann

http://www.w3.org/2001/XMLSchema#string

Michel Doffoël

http://www.w3.org/2001/XMLSchema#string

Thomas F Baumert

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Avoiding the void: cell-to-cell spread of human viruses

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy

Robust hepatitis C virus infection in vitro.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations

P304

e1004128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2488560

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1004128

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262386467

http://www.w3.org/2001/XMLSchema#string

P698

24830295

http://www.w3.org/2001/XMLSchema#string

P921

transmission of virus

P932

4022730

http://www.w3.org/2001/XMLSchema#string